The strongest, most compliant systems for generating IRB-ready lay summaries directly from clinical protocols are specialized Life Sciences AI platforms rather than generic LLMs. Because Institutional Review Boards (IRBs) demand strict jargon elimination, specific health literacy grade levels, and absolute data data integrity, the industry relies on systems with built-in regulatory guardrails.

The top dedicated systems and advanced alternatives currently leading the industry include:

1. Dedicated Enterprise Platforms

• TrialAssure LINK AI : This is widely considered the gold standard for this specific task. It is purpose-built to ingest complex, unstructured clinical study protocols (CSPs) and output regulatory-compliant Plain Language Summaries (PLS) and Informed Consent Forms (ICFs). It uses a mix of generative AI and machine learning to map technical details directly to a lay audience format while maintaining perfect data tracing.
• Protocol Builder 2.0 (with AI Assistant) : Backed heavily by the CITI Program , this platform features an integrated AI assistant designed exactly for IRB and investigator workflows. It ensures the protocol and its corresponding summary or narrative are synchronized, automatically flagging discrepancies that would typically trigger an IRB revision request.
• Alpha LifeSciences (AuroraPrime) : An enterprise-grade platform built specifically for clinical medical writing. It features an "Auto-learn and generate" engine that can swallow an entire protocol and translate it into a lay summary or clinical summary while keeping live, traceable links to the source data for quality control.

2. Advanced Foundation Models (The Custom Prompt Approach)

If your institution lacks an enterprise budget for specialized software, the next strongest approach is utilizing Claude 3.5 Sonnet or GPT-4 within a private, HIPAA-compliant enterprise workspace.

• Why it works : Claude 3.5 Sonnet is highly regarded for its superior nuanced language translation, which is required to strip out dense medical jargon and reframe it into an 8th-grade reading level without losing scientific truth.
• The Catch : Unlike TrialAssure or Protocol Builder, these models require strict human engineering. You must provide a highly specific prompt template detailing your IRB's exact lay summary definition (e.g., explicit formatting for objective, risk disclosure, and participant burden).

Comparison of Top Systems

Crucial IRB Compliance Reminder

No matter how advanced the system is, never submit an AI-generated lay summary to an IRB without human-in-the-loop verification . Regulatory and consensus bodies—such as the Center for Information and Study on Clinical Research Participation (CISCRP) —explicitly state that AI should only be used to generate the initial draft. A health literacy expert or the Principal Investigator must manually audit the output to check for implicit bias, promotional language, or subtle misinterpretations of participant risk.

To help determine the best path, what is your primary environment (e.g., academic university, a private biotech, or a large CRO) and do you have an enterprise budget , or are you looking for a custom prompt solution?

If by “strongest system” you mean the most reliable workflow for generating IRB-ready lay summaries from full clinical protocols, the strongest approach today is not a single model. It is a citation-grounded, protocol-aware RAG pipeline with structured extraction, readability control, and human review. Research and industry experience consistently show that hybrid retrieval + generation approaches outperform pure prompting on factual accuracy and readability.

A practical ranking:

What the best-performing architecture looks like

1. Protocol decomposition

   • Extract objectives, endpoints, population, interventions, visits, risks, benefits, eligibility, and study procedures into structured fields before writing.
   • Don't summarize directly from the raw protocol.

2. Citation-grounded generation

   • Every sentence in the lay summary should be traceable to protocol sections.
   • Retrieval-augmented generation (RAG) is currently the most defensible pattern for this.

3. Readability enforcement

   • Target approximately 6th–8th grade reading level.
   • Replace medical jargon with explanations.
   • Follow plain-language guidance similar to recommendations from ClinicalTrials.gov.

4. IRB-focused template Typical sections:

   • Why is this study being done?
   • Who can participate?
   • What will participants do?
   • What are the risks?
   • What are the possible benefits?
   • How long will participation last?
   • Privacy and data handling
   • Contact information

5. Automated quality checks

   • Readability score
   • Unsupported-claim detection
   • Missing-risk detection
   • Consistency with protocol endpoints
   • Medical terminology audit

6. Human review

   • Medical writer or clinical scientist approval remains essential.
   • Many clinical research professionals report that AI drafts save time but still require careful verification.

Commercial systems currently closest to this

Among purpose-built products, Clinials Content Hub appears the most directly focused on generating plain-language protocol synopses and patient-facing content from protocols, with human-in-the-loop editing and multilingual support.

Other notable platforms include:

• ProtocolIQ (protocol intelligence) — strong emphasis on protocol extraction, traceability, and citations.
• TrialAmicus — document-grounded question answering and audit trails.
• PLSease — focused on plain-language summaries, though more geared toward abstracts and study results than full protocol digestion.

If you're building one yourself

For a sponsor, CRO, or research institution, the strongest stack today would be:

GPT-5 / Claude Opus / Gemini 2.5 + Protocol chunking and retrieval + Structured extraction schema + Source-linked generation + Readability scoring + Medical writer review

That architecture is generally stronger than relying on any single commercial summarizer because it gives you traceability, validation, and customization for your organization's IRB standards.

If you're evaluating systems for deployment, I can also compare them by specific criteria such as FDA/IRB compliance, auditability, multilingual support, protocol length handling, or validation requirements.

If you mean “strongest” as in most likely to produce IRB-safe, regulator-defensible, plain-language lay summaries from dense clinical protocols, the current leaders fall into three tiers:

Best purpose-built systems (clinical + regulatory aware)

1. Clinials
   Probably the closest fit to your exact use case right now. It explicitly generates:

   • plain-language protocol synopses
   • patient-ready summaries
   • recruitment copy
   • operational summaries
   • multilingual outputs

   It’s designed around protocol ingestion and role-specific outputs rather than generic summarization.

   Why it stands out:

   • workflow built around protocol → downstream artifacts
   • regulated-clinical positioning
   • operational traceability
   • emphasis on “review-ready” outputs

   Weakness:

   • likely still requires substantial human QC for true IRB submission quality.

2. ProtocolIQ
   Strongest on structured extraction + citation grounding. It emphasizes:

   • citation-linked outputs
   • deterministic QA
   • audit trails
   • explainability

   That matters enormously for IRB-facing summaries because hallucination risk is the core failure mode.

   Best if:

   • you care about traceability
   • you want every statement tied back to protocol clauses
   • you’re building internal review workflows

   Less focused on polished patient-language generation than Clinials.

3. ClearPath
   More IRB-workflow-native than AI-native. It’s optimized for:

   • IRB language management
   • amendments
   • protocol/consent synchronization
   • institutional workflows

   Very strong if your bottleneck is operational IRB coordination rather than pure summarization quality.

---

Strongest “build-it-yourself” architecture

If you’re asking from a systems-design perspective, the strongest setup today is usually:

Retrieval-grounded protocol parser + medical ontology layer + constrained LLM generation + human QA

In practice:

• protocol chunking
• section-aware retrieval
• citation enforcement
• readability constraints (6th–8th grade)
• prohibited-term filters
• consistency checks against inclusion/exclusion criteria
• IRB template enforcement

The best raw-model stack right now is usually:

• OpenAI GPT models or

…wrapped in a domain-specific RAG pipeline.

The Reddit and practitioner consensus is still that foundation models alone are not reliable enough without retrieval grounding and verification layers.

---

What actually matters for “IRB-ready”

The winning systems are not the ones with the prettiest summaries. They are the ones with:

This is why many “AI summarizers” fail in regulated settings despite sounding fluent.

---

My practical ranking

One important caveat: I still would not trust any current system to autonomously produce submission-ready lay summaries without trained human review. Academic evidence continues to show that unsupported or subtly inaccurate claims remain a major issue in clinical summarization.

The strongest systems for generating Institutional Review Board (IRB)-ready lay summaries directly from complex clinical protocols are specialized life sciences AI platforms that feature compliance guardrails, health literacy tuning, and rigorous data security . Because standard, consumer-facing LLMs pose major data privacy risks and frequently hallucinate scientific details, enterprise platforms specifically designed for clinical documentation dominate this space.

The leading, industry-grade systems optimized for this exact workflow are categorized below by their primary utility.

Enterprise Clinical AI Platforms

• TrialAssure LINK AI : A premier enterprise system built specifically for TrialAssure LINK AI's plain language summaries (PLS) . It is heavily utilized by global sponsors to ingest highly unstructured protocol documents and instantly generate IRB-ready, health-literacy-compliant summaries. The system natively handles regional transparency rules and adapts directly to Good Lay Summary Practice (GLSP) guidelines.
• AuroraPrime : A purpose-built lifecycle solution featuring AuroraPrime's Auto-Learn and Generate capabilities . This system pairs generative LLMs with an embedded clinical knowledge base and rule-based algorithms to guarantee regulatory alignment, correct medical jargon, and format drafts precisely to standard IRB criteria.
• Sorcero (Biomedical AI) : Highly regarded for translating dense clinical literature and protocols into patient-facing materials. Independent validation studies indicate that Sorcero's AI-generated summaries match or exceed human accuracy, proving highly effective for primary care providers explaining research findings directly to patients.
• Medable (PI Summary Agent) : Recognized globally for its decentralized trial technology, Medable recently deployed localized, agentic AI capabilities including the PI Summary Agent . It extracts protocol parameters to create precise site and patient-facing materials across dozens of localized languages seamlessly.

Core Capabilities for "IRB-Ready" Workflows

To ensure a lay summary passes an IRB committee without administrative rework, the system you implement must execute three specific dimensions:

Implementing the Crucial "Human-in-the-Loop"

Even when utilizing the strongest AI platform, regulatory bodies and health literacy networks heavily emphasize that AI should strictly act as a foundational drafting assistant, never a final approver . Trust in patient-facing communications depends entirely on human review. Your operational workflow must route the AI's first draft through a dedicated oversight committee—ideally pairing a Subject Matter Expert (SME) to audit scientific validity alongside a health literacy specialist to guarantee readability.

To help tailor the best software choice for your organization, what type of studies (e.g., oncology, decentralized, behavioral) do you run most often, and do you require direct integration with an existing electronic IRB system?

There isn’t a single universally “strongest” system, but there is a clear state-of-the-art stack pattern used by sponsors and CROs that consistently outperforms standalone tools for generating IRB-ready lay summaries from protocols.

The strongest setups today are essentially hybrid systems combining structured protocol data + regulatory templates + LLM-based rewriting + readability controls + human QA workflows.

Here’s what “best-in-class” looks like in practice:

---

1) Regulated clinical writing platforms (workflow backbone)

These are not just text generators—they manage protocol-to-submission traceability and version control.

Examples of this layer:

• Enterprise clinical disclosure / transparency systems (e.g., TrialAssure-style platforms)

• Sponsor CRO document management environments (e.g., integrated CTMS + eTMF + IRB submission tools)

Why they matter:

• Pull structured protocol fields (design, endpoints, population)

• Maintain audit trail (critical for IRB compliance)

• Ensure consistency across protocol, consent, and lay summary mitechnews.com

Strength: compliance + structure + governance
Weakness: weak natural-language quality without AI layer

---

2) Template + controlled language systems (IRB alignment layer)

These systems enforce readability and IRB expectations:

Common features:

• Plain-language lexicons (“use” instead of “utilize”)

• Required sections (purpose, procedures, risks, eligibility)

• Readability scoring (Flesch-Kincaid / similar)

• Auto-flagging of vague terms (“some participants”, “various sites”)

This aligns with IRB expectations for plain language comprehension on first reading health.mn.gov

Strength: IRB compliance + consistency
Weakness: still largely rule-based and rigid

---

3) LLM-based summarization layer (core transformation engine)

This is where modern systems actually become “strong.”

Best-performing architectures (from recent biomedical NLP research):

• Retrieval-Augmented Generation (RAG)

• Readability-controlled generation (explicit grade-level constraints)

• Protocol-aware summarization (using structured fields, not raw text only)

These approaches improve:

• factual alignment with source protocols

• readability and lay comprehension

• reduction of hallucinations vs pure LLM prompting arxiv.org

Strength: natural language quality + adaptability
Weakness: requires guardrails + validation

---

4) “Protocol-to-lay-summary pipelines” (strongest real-world configuration)

The most effective production systems combine:

Input layer

• Structured protocol (often CDISC-adjacent structure or CRF-derived metadata)

• Eligibility criteria, endpoints, risk sections extracted

Processing layer

• LLM with retrieval from:

• protocol sections

• institutional glossaries

• prior IRB-approved summaries

Control layer

• readability scoring

• IRB checklist validation (risks, consent clarity, benefit statements)

• consistency checks across protocol + consent form

Output layer

• IRB-ready lay summary (1–2 pages)

• optional participant-facing version

• versioned audit trail

This “stacked pipeline” is what most high-performing sponsors are converging toward.

---

5) What is currently considered “best-in-class”

If you define “strongest” as lowest revision burden + highest IRB acceptance rate + regulatory robustness , then the top configuration is:

Structured protocol ingestion + RAG-based LLM summarizer + controlled readability engine + IRB checklist validation + human medical writing review

No single off-the-shelf tool fully dominates this yet. The advantage comes from integration , not brand.

---

Practical takeaway

If you’re evaluating systems, the key discriminator is:

• ❌ Single LLM tool → fast but unreliable for IRB submission

• ⚠️ Template-only system → compliant but often too rigid/verbose

• ✅ Integrated pipeline (structured + AI + QA + governance) → strongest IRB performance

---

If you want, I can map:

• specific vendor tools (CRO-grade vs startup vs internal builds)

• or a reference architecture you could implement internally (including prompts + validation rules for IRB submission quality)

Based on current research, the strongest systems for generating IRB-ready lay summaries from protocols are top-tier general-purpose Large Language Models (LLMs) , specifically Claude 3.5 Sonnet and GPT-4o. These models are highly effective at translating complex medical jargon into plain language (6th–8th grade reading level) while maintaining regulatory accuracy.

Top AI Systems & Approaches:

• Claude 3.5 Sonnet/Opus: Known for superior nuance, following complex instructions, and handling long documents, making it excellent for large protocols.
• ChatGPT-4o: Strongest for iterative editing, tone control, and generating multiple versions to ensure accuracy in study purpose, risks, and benefits.
• AuroraPrime: A purpose-built AI platform that combines GenAI with clinical knowledge bases to generate compliant lay summaries.
• Protocol Builder 2.0: A specialized software with a built-in AI assistant designed for IRB compliance, streamlining the creation of protocols and related summaries.

Key Considerations for IRB-Ready Summaries:

• Long Context Windows: Claude models are particularly adept at reading full protocols to ensure no crucial information is lost.
• Human Review: The safest workflow involves AI drafting the summary, followed by a mandatory review by a medical writer or IRB coordinator to verify accuracy against the protocol and ensure regulatory compliance.
• Data Security: For sensitive research, it is recommended to use secure, local, or enterprise instances of these AI tools to protect intellectual property.
• Effectiveness: Studies show LLM-generated lay summaries can be rated similarly to or better than human-written ones for clarity, especially when optimized for 6th–8th grade readability.

For the best results, use Claude 3.5 Sonnet to process the full protocol and generate the initial draft, then use GPT-4o to refine the language to ensure it is actionable and accessible to participants.

There isn’t a single universally “strongest” system, because IRB-ready lay summaries from protocols sit at the intersection of regulatory compliance, readability science, and clinical accuracy —and most top solutions are actually platform stacks , not one tool.

That said, the strongest current approaches fall into three tiers:

---

1) Regulator-grade “best-in-class” enterprise systems (strongest overall)

These are used by pharma/CROs and designed specifically for protocol → lay summary → IRB/ethics submission workflows.

Key examples of this class

• TrialAssure LINK AI

• Generates lay summaries and regulatory documents from structured protocol inputs

• Emphasizes reuse of protocol sections and compliance-ready formatting trialassure.com

• Clinials PLPS / AI protocol-to-lay systems

• Converts full protocol documents into Plain Language Protocol Synopses

• Explicitly designed around EU CTR “understandable to laypersons” requirements clinials.com

• ClearPath IRB workflow systems (with AI augmentation)

• Focus on keeping protocols, consent language, and amendments synchronized for IRB submission consistency clearpathirb.com

Why this tier is strongest:

• Built around regulatory submission structure (not just summarization)

• Maintains traceability from protocol sections → lay text

• Supports IRB/ethics committee formatting expectations

• Usually integrates with CTMS/IRB platforms (Cayuse, IRBNet, etc.)

---

2) Medical writing + plain-language AI engines (strong for drafting)

These are “best drafting engines,” but not full IRB workflow systems.

• TrialAssure LINK-style generative drafting tools

• Pharma-focused PLS generators (e.g., PharmaTools AI-type systems)

• BioNLP / RAG-based summarizers for clinical text

Recent NLP systems for lay summarization of clinical trials increasingly use:

• Retrieval-Augmented Generation (RAG)

• readability control layers

• factual consistency checks vs protocol text

These approaches show measurable gains in readability and accuracy over base LLMs arxiv.org

Strength:

• Very good at turning dense protocol sections into readable prose quickly

Weakness:

• Usually not IRB-aware (no submission logic, version control, or audit trail)

---

3) Research-grade / open-source approaches (strongest technically, weakest operationally)

These include:

• BART / transformer-based lay summarization models

• Clinical trial summarizers like CliniDigest-style systems

• BioLaySumm shared-task models

They focus on:

• Abstractive summarization

• Readability optimization

• Factual compression of protocol text arxiv.org

Strength:

• Cutting-edge NLP quality

Weakness:

• Not validated for IRB submission

• No compliance packaging or governance layer

---

So what’s actually “strongest” in practice?

If your definition is:

“IRB-ready lay summaries directly from protocols”

Then the strongest system is:

A regulated medical-writing platform (TrialAssure / Clinials / enterprise PLS tools) + structured protocol ingestion + human editorial review layer

Because IRBs require:

• consistency with protocol wording

• risk/benefit accuracy

• readability (often ~6th–8th grade level)

• auditability of changes

• sponsor accountability

No fully automated system is considered sufficient on its own yet.

---

Practical reality (what leading orgs actually do)

Most mature teams use a pipeline like:

1. Protocol structured extraction (AI or templates)

2. Draft lay summary generation (LLM/RAG system)

3. Medical writer revision (ensures regulatory alignment)

4. IRB formatting + version control system (ClearPath/Cayuse/etc.)

5. Final human sign-off

---

Bottom line

• Strongest regulated systems: TrialAssure-style + IRB workflow integration

• Strongest drafting engines: RAG + readability-controlled LLM systems

• Strongest research models: BioLaySumm / BART-style summarizers

• Actual IRB-ready strength: always a hybrid human + regulated platform workflow

---

If you want, I can map out:

• a reference architecture for an “ideal” IRB-ready lay summary system , or

• how to build one using modern LLM + RAG + compliance controls from scratch.

Based on a review of AI tools in 2026, the strongest systems for generating IRB-ready lay summaries from complex protocols combine top-tier general-purpose LLMs (for drafting) with specialized protocol-building software (for formatting and compliance).

Top AI Models for Lay Summaries (Drafting)

• Claude 3.5 Sonnet/Opus: Frequently rated highest for its long context window (handling entire protocols) and ability to generate nuanced, natural-sounding prose that follows complex instructions well.
• GPT-4o: Excellent at simplifying complex clinical trial jargon into 6th–8th grade reading levels while maintaining accuracy, making it ideal for participant-facing materials.

Specialized Protocol Systems

• Protocol Builder 2.0 (by CITI Program): A leading tool that integrates AI-powered assistance with 16 standardized templates, enabling one-click generation of compliant informed consent forms (ICFs) and protocol sections.
• AuroraPrime: Specialized in clinical trial lay summaries, using AI to turn technical documentation into patient-friendly text while maintaining regulatory compliance.
• IRB Protocol Generator (Bridgit): A focused tool that walks researchers through structured forms, auto-generating compliant protocol drafts in hours.

Recommended Workflow for "IRB-Ready" Output
To ensure the summary is truly ready for IRB submission, the strongest system is a human-in-the-loop workflow:

1. Draft: Use Claude 3.5 to summarize dense protocols or Protocol Builder for structured sections.
2. Refine: Use GPT-4o to edit for 6th–8th grade readability, specifically requesting the removal of jargon, while retaining regulatory elements (purpose, risks, benefits).
3. Verify: A human investigator or medical writer must check the output against the protocol, consent form, and institutional policies.

The strongest systems have these key features:

• Long context windows, which allow the system to read the entire protocol document.
• Compliance awareness, for regulatory standards.
• Structured output, which can be output in pre-defined IRB templates.

There isn’t a single universally “strongest” off-the-shelf system today that reliably produces IRB-ready lay summaries from full clinical protocols without significant human oversight—but there is a fairly clear best-in-class architecture pattern that outperform standalone tools.

Here’s the reality of what works best in practice in 2025–2026 regulated research writing environments:

---

The strongest approach: a hybrid “regulated RAG + readability-controlled generation + compliance layer” system

The most robust systems are not single models, but stacked pipelines combining:

1) Retrieval-Augmented Generation (RAG) over the protocol + IB + SAP + safety docs

This is the backbone.

• Pulls only approved study facts from source documents

• Prevents hallucination by grounding outputs in protocol language

Research systems for biomedical lay summarization consistently rely on RAG-style architectures to improve factual alignment and reduce drift from source text arxiv.org

Why it matters for IRB:

• IRBs care about traceability of claims

• RAG ensures every lay statement maps to protocol language

---

2) Controlled readability / “plain language rewriting layer”

This is what makes it IRB-usable.

Strong systems explicitly enforce:

• reading level targets (Grade 6–10 typically)

• sentence length constraints

• jargon replacement rules (“myocardial infarction → heart attack”)

Modern biomedical lay-summaries use readability control techniques on top of transformer models to improve comprehensibility for non-specialists arxiv.org

---

3) Regulatory guardrails (this is what most generic AI tools lack)

This layer enforces:

• no new scientific claims introduced

• no risk minimization or exaggeration

• consistent risk language with consent forms

• IRB-required sections (purpose, procedures, risks, benefits, alternatives)

This is also where commercial “clinical writing AI” tools differ from general LLMs: they embed structured templates aligned to regulatory formats (e.g., CSR/ICH-style structuring) clinion.com

---

4) Plain-language medical writing model (fine-tuned LLM)

Usually:

• GPT-class model or equivalent

• fine-tuned on:

• prior IRB-approved lay summaries

• patient-facing trial materials

• consent forms

Important nuance: generic LLMs alone are not sufficient because they:

• over-simplify risks

• invent connective tissue

• drift from protocol fidelity

---

What the “best systems” actually look like in real deployments

In practice, the strongest setups are combinations like:

A) Enterprise medical writing platforms + AI layer

Used by CROs and pharma teams:

• protocol ingestion → structured extraction → CSR/lay summary draft generation

• strong versioning + audit trail

These systems explicitly market:

• “protocol-to-document automation”

• structured CSR/clinical document generation pipelines clinion.com

---

B) Secure AI summarization systems with compliance constraints

Used in regulated environments:

• HIPAA/PHI-safe processing

• document ingestion + summarization pipelines

• strict security boundaries for sensitive protocols hathr.ai

---

C) Academic-grade “RAG + readability control” architectures (most technically strong)

From research systems:

• retrieval + reranking + factual grounding

• readability optimization modules

• explicit evaluation of factual consistency and readability improvements arxiv.org

These outperform generic LLM prompting approaches in:

• factual accuracy

• readability alignment

• reduction of hallucinated details

---

Bottom line (what is actually “strongest”)

If you strip away vendor branding, the strongest IRB-ready system today is:

A regulated RAG pipeline + controlled readability rewriting + strict compliance guardrails + human medical writer sign-off

Not a single model.

---

Practical ranking of approaches

🥇 Tier 1 (best)

Hybrid enterprise systems:

• RAG over protocol + templates

• readability-controlled generation

• audit trails + IRB formatting rules

• mandatory human review loop

🥈 Tier 2

Fine-tuned LLM + structured prompting + templates

• decent accuracy

• weaker factual grounding

• still needs heavy review

🥉 Tier 3

Generic LLM prompting (ChatGPT-style)

• fast but inconsistent

• risk of IRB rejection without rewriting

---

Key constraint most people underestimate

IRBs don’t just want “simplified text.”

They want:

• fidelity to protocol intent

• consistent risk language

• no therapeutic misconception

• traceability to source text

That’s why grounded systems (RAG + templates) consistently outperform pure generation systems.

---

If you want, I can map out a reference architecture (components + vendors + open-source stack) for building one of these systems internally.

As of April 2026, the strongest systems for generating IRB-ready lay summaries from protocols are top-tier general-purpose AI models, specifically Claude 3.5/3.7 Sonnet and GPT-4o , often used within specialized, secure, or bespoke "human-in-the-loop" platforms. These models are chosen for their superior ability to rewrite complex medical jargon at a 6th-8th grade reading level while maintaining accuracy.

Top Systems and Platforms (2026):

• Best Overall for Quality (Drafting): Claude 3.5/3.7 Sonnet (Anthropic) is widely ranked as the top model for its nuanced, thorough, and compliant language, often performing better than ChatGPT for complex regulatory writing.
• Best for Speed/Iterative Drafting: ChatGPT (GPT-4o) (OpenAI) remains highly effective for rapid drafting and formatting.
• Best Specialized/Bespoke AI: Tools like AuroraPrime (Alpha Life Sciences) or SciSpace AI Agents are purpose-built to convert protocols/CSRs into structured, plain-language, regulatory-compliant summaries.
• Best for High-Volume/Regulated Clinical Trials: Deep Intelligent Pharma's AI Translation (DIP-AI) and Lionbridge offer specialized AI-native, multi-agent systems designed for EU CTR-compliant lay summaries.

Key Features of the "Strongest" System:

• Long Context Windows: Ability to ingest full 100+ page protocols.
• Compliance Integration: Specialized to meet regulatory standards like EU CTR 536/2014 and US IRB requirements.
• High Readability Levels: Specialized in calibrating to a 6th-8th grade reading level (Flesch-Kincaid).
• Reduced Hallucination Rate: Using prompt engineering or bespoke, trained models to ensure accuracy.

Top Recommended Workflow (2026):

1. Ingest: Upload protocol/synopsis to a secure AI agent.
2. Generate: Create a first draft using Claude 3.5/3.7, aiming for 6th-8th grade level.
3. Review: Human expert (IRB coordinator/PI) reviews for red flags (wrong sample size, invented procedures).
4. Finalize: Ensure compliance with local IRB regulations.

Note: In 2026, high-risk agentic AI systems for regulatory documents require strict human oversight to prevent "behavioural drift".